NO975545D0 - Cellelinje som produserer analgetiske forbindelser for behandling av smerte - Google Patents

Cellelinje som produserer analgetiske forbindelser for behandling av smerte

Info

Publication number
NO975545D0
NO975545D0 NO975545A NO975545A NO975545D0 NO 975545 D0 NO975545 D0 NO 975545D0 NO 975545 A NO975545 A NO 975545A NO 975545 A NO975545 A NO 975545A NO 975545 D0 NO975545 D0 NO 975545D0
Authority
NO
Norway
Prior art keywords
pain
treatment
cell line
analgesic compounds
produces analgesic
Prior art date
Application number
NO975545A
Other languages
English (en)
Other versions
NO975545L (no
Inventor
Joel Saydoff
Shou Wong
Original Assignee
Cytotherapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytotherapeutics Inc filed Critical Cytotherapeutics Inc
Publication of NO975545D0 publication Critical patent/NO975545D0/no
Publication of NO975545L publication Critical patent/NO975545L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/87Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70Enkephalins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00Genetically modified cells
    • C12N2510/02Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO975545A 1995-06-07 1997-12-02 Cellelinje som produserer analgetiske forbindelser for behandling av smerte NO975545L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48191795A 1995-06-07 1995-06-07
PCT/US1996/009629 WO1996040959A1 (en) 1995-06-07 1996-06-07 Cell line producing analgesic compounds for treating pain

Publications (2)

Publication Number Publication Date
NO975545D0 true NO975545D0 (no) 1997-12-02
NO975545L NO975545L (no) 1998-02-04

Family

ID=23913905

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975545A NO975545L (no) 1995-06-07 1997-12-02 Cellelinje som produserer analgetiske forbindelser for behandling av smerte

Country Status (20)

Country Link
EP (1) EP0833935A1 (no)
JP (1) JPH11507530A (no)
KR (1) KR19990022414A (no)
CN (1) CN1192246A (no)
AR (1) AR004494A1 (no)
AU (1) AU6263696A (no)
BR (1) BR9608746A (no)
CA (1) CA2223246A1 (no)
CZ (1) CZ392497A3 (no)
EE (1) EE9700326A (no)
HU (1) HUP9901191A2 (no)
IL (1) IL122415A0 (no)
IN (1) IN181898B (no)
IS (1) IS4628A (no)
NO (1) NO975545L (no)
PL (1) PL323867A1 (no)
SK (1) SK167997A3 (no)
TR (1) TR199701520T1 (no)
WO (1) WO1996040959A1 (no)
ZA (1) ZA964880B (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999028449A2 (en) * 1997-11-28 1999-06-10 Medical Research Council Yac vectors
AU6151899A (en) * 1998-09-23 2000-04-10 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Methods of treating chronic pain
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
ATE312916T1 (de) * 1998-10-27 2005-12-15 Anticancer Inc Herstellung eines retrovirus, welches den mel- lokus von streptomyces enthält, sowie dessen expression in säugetierzellen
US6903244B1 (en) 1999-02-26 2005-06-07 University Of Utah Research Foundation Mice which are +/− or −/− for the elastin gene as models for vascular disease
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
NZ547767A (en) 2003-12-24 2010-05-28 Inst Medical W & E Hall Therapeutic agents and uses therefor
WO2005108981A1 (en) 2004-05-12 2005-11-17 The Walter And Eliza Hall Institute Of Medical Research A method of cell isolation
DK1910535T3 (en) 2005-06-24 2016-09-26 The Walter And Eliza Hall Inst Of Medical Res Therapeutic pro-apoptotic BH-3-like molecules and method of forming and / or selecting the same
WO2008011006A2 (en) 2006-07-18 2008-01-24 University Of Utah Research Foundation Methods for treating pain and screening analgesic compounds
US8889173B2 (en) * 2008-04-18 2014-11-18 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of pain and/or inflammation
KR20160019469A (ko) 2013-05-31 2016-02-19 더 유니버시티 오브 유타 리서치 파운데이션 코노톡신 펩티드, 제약 조성물 및 그의 용도
WO2017070738A1 (en) 2015-10-27 2017-05-04 The University Of Queensland A method of treatment and agents useful for same
CN107964047B (zh) * 2017-12-18 2018-11-02 哈尔滨工业大学 基于内***肽-1和神经降压素(8-13)的嵌合肽及其合成方法和应用
CN112891337A (zh) * 2021-03-26 2021-06-04 河北医科大学 高良姜素及其衍生物在制备预防和治疗神经***疾病药物中的用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69430824T2 (de) * 1993-08-12 2003-01-23 Neurotech Sa Biokompatible immunoisolatorische Kapseln, die genetisch veränderte Zellen enthalten

Also Published As

Publication number Publication date
WO1996040959A1 (en) 1996-12-19
AU6263696A (en) 1996-12-30
KR19990022414A (ko) 1999-03-25
CN1192246A (zh) 1998-09-02
BR9608746A (pt) 1999-05-11
TR199701520T1 (xx) 1998-04-21
AR004494A1 (es) 1998-12-16
IS4628A (is) 1997-12-04
IN181898B (no) 1998-10-24
NO975545L (no) 1998-02-04
CA2223246A1 (en) 1996-12-19
CZ392497A3 (cs) 1998-12-16
SK167997A3 (en) 1998-05-06
JPH11507530A (ja) 1999-07-06
IL122415A0 (en) 1998-06-15
PL323867A1 (en) 1998-04-27
EP0833935A1 (en) 1998-04-08
HUP9901191A2 (hu) 1999-08-30
EE9700326A (et) 1998-06-15
ZA964880B (en) 1997-01-07

Similar Documents

Publication Publication Date Title
ZA961150B (en) Substituted isoxazoles for the treatment of inflammation.
NO976063D0 (no) Fremgangsmåte for behandling av diabetes
NO982172D0 (no) Anvendelse av epinastin for behandling av smerter
NO965377L (no) Indolinonforbindelser for behandling av sykdommer
NO984431L (no) FremgangsmÕte for behandling av smerte
ATE192157T1 (de) Therapeutisch verwendbare spiro-azabicyclische verbindungen
ATE193298T1 (de) Therapeutische verbindungen
NO990225D0 (no) Medikamenter for behandling av hyperfosfatemi
NO975545D0 (no) Cellelinje som produserer analgetiske forbindelser for behandling av smerte
AU2424895A (en) Substituted spirodienes for the treatment of inflammation
PT777457E (pt) A utilizacao de triacetato de glicerilo para o tratamento de onicomicoses
NO984446D0 (no) FremgangsmÕte for behandling av smerte
NO984432L (no) FremgangsmÕte for behandling av migrenesmerte
IS4768A (is) Ný efnasambönd sem hafa verkjastillandi áhrif
NO982582D0 (no) FremgangsmÕte for behandling av smerte
NO974569L (no) Benzamider for behandling av neurodegenerative forstyrrelser
NO982562D0 (no) Sammensetning for behandling av smerte
NO973366D0 (no) Fremgangsmåte for behandling av multippel sklerose
DK0866699T3 (da) Anvendelse af cholinesteraseinhibitorer til fremstilling af et medikament til behandling af xerostomi
NO20001894D0 (no) Anvendelse av TNF-antagonister som medikamenter for behandling av septiske sykdommer
NO993549D0 (no) Imino-aza-antracyklinonderivater til behandling av amyloidosis
DE69606320T2 (de) Bohrlochbehandlungsflüssigkeit
NO986053D0 (no) Antikonvulsive derivater for behandling av psoriasis
DE69528372D1 (de) Orale behandlung
KR960028346U (ko) 쑥뜸기